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Cellular/Molecular
The C-Type Natriuretic Peptide Induces Thermal
Hyperalgesia through a Noncanonical G-dependent
Modulation of TRPV1 Channel
Lipin Loo,1 Andrew J. Shepherd,1 Aaron D. Mickle,1 Ramo´n A. Lorca,1 Leonid P. Shutov,1 Yuriy M. Usachev,1,2
and Durga P. Mohapatra1,2
Departments of 1Pharmacology and 2Anesthesia, Roy J. and Lucile A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242
Natriuretic peptides (NPs) control natriuresis andnormalize changes inbloodpressure.Recent studies suggest thatNPs are also involved
in the regulation of pain sensitivity, although the underlyingmechanisms remain essentially unknown.Manybiological effects ofNPs are
mediated by guanylate cyclase (GC)-coupledNP receptors, NPR-A andNPR-B,whereas the thirdNP receptor, NPR-C, lacks theGCkinase
domain and acts as the NP clearance receptor. In addition, NPR-C can couple to specific Gi–G-mediated intracellular signaling
cascades in numerous cell types. We found that NPR-C is coexpressed in transient receptor potential vanilloid-1 (TRPV1)-expressing
mouse dorsal root ganglia (DRG) neurons. NPR-C can be coimmunoprecipitated with Gi , and C-type natriuretic peptide (CNP) treat-
ment induced translocation of protein kinase C (PKC) to the plasma membrane of these neurons, which was inhibited by pertussis
toxin pretreatment. Application of CNP potentiated capsaicin- and proton-activated TRPV1 currents in cultured mouse DRG neurons
and increased their firing frequency, an effect that was absent in DRG neurons from TRPV1/ mice. CNP-induced sensitization of
TRPV1 activity was attenuated by pretreatment of DRG neurons with the specific inhibitors of G, phospholipase C- (PLC), or PKC,
but not of protein kinaseA, andwas abolishedbymutations at twoPKCphosphorylation sites inTRPV1. Furthermore, CNP injection into
mouse hindpaw led to the development of thermal hyperalgesia that was attenuated by administration of specific inhibitors of G or TRPV1
andwas also absent in TRPV1/mice. Thus, ourwork identifies theG–PLC–PKC-dependent potentiation of TRPV1 as a novel signaling
cascade recruited by CNP inmouseDRGneurons that can lead to enhanced nociceptor excitability and thermal hypersensitivity.
Introduction
Natriuretic peptides (NPs) mediate natriuresis to provide ho-
meostatic control of body water, Na and K electrolytes, and
fat, as well as playing a critical role in normalizing changes in
blood pressure (Suzuki et al., 2001; Pandey, 2005b; Moro and
Berlan, 2006; Potter et al., 2009). These events are mediated via
downstream cellular signaling events, resulting from the activa-
tion of guanylate cyclase (GC)-coupled natriuretic peptide recep-
tors, NPR-A and NPR-B, by atrial-type (ANP), brain-type
(NBP), and C-type (CNP) natriuretic peptides (Pandey, 2005b;
Potter et al., 2006, 2009). Additionally, NPs have been implicated
in sensory nerve fiber sprouting and bifurcation (Kishimoto et
al., 2008; Schmidt et al., 2009), as well as regulation of pain sen-
sitivity (Schmidtko et al., 2008a; Zhang et al., 2010; Heine et al.,
2011). Activation of protein kinase G (PKG) downstream of
BNP/NPR-A in dorsal root ganglia (DRG) neurons has been
shown to mediate the negative regulation of nociceptive trans-
mission via modulation of presynaptic BKCa channel activity in
the dorsal horn of the spinal cord (Zhang et al., 2010). Con-
versely, a recent report showed enhanced mechanical hypersen-
sitivity in rats upon intrathecal injection of CNP (Heine et al.,
2011). The canonical NPR-A- and NPR-B-mediated down-
stream cGMP/PKG signaling pathwaysmediate all these effects of
BNP andCNP, respectively (Schmidtko et al., 2008a; Zhang et al.,
2010; Heine et al., 2011). NPR-C is an additional NP receptor
that, unlike NPR-A and NPR-B, lacks the GC kinase domain and
thereby serves as the NP clearance receptor (Pandey, 2005a; Pot-
ter et al., 2006). However, NPR-C has also been shown to signal
through the pertussis toxin (PTX)-sensitive Gi protein in a va-
riety of cell types, inwhich its activationbyCNP(andANP) leads to
specific Gi/o/ downstream signaling, including G-mediated
phospholipase C- (PLC) activation, phosphatidylinositol-
4,5-biphosphate (PIP2) hydrolysis, and subsequent activation of
protein kinase C (PKC) (Levin, 1993; Murthy and Makhlouf, 1999;
Murthy et al., 2000; Anand-Srivastava, 2005).
Vascular endothelial cells secrete elevated levels of CNP
during stimulation by inflammatory mediators, such as interleu-
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kin-1/ (IL-1/), tumor necrosis factor- (TNF-), and lipo-
polysaccharide (Suga et al., 1993). Furthermore, increased serum
CNP levels were found in human patients with rheumatoid ar-
thritis and systemic sclerosis (Olewicz-Gawlik et al., 2010a,b).
These findings suggest that CNP plays a role in vascular inflamma-
tion (Ahluwalia and Hobbs, 2005) and possibly in inflammatory
pain sensitization. The transient receptor potential vanilloid-1
(TRPV1) channel on sensory afferents is a key mediator of periph-
eral sensory detection and transduction of inflammatory pain.
Mechanistically, this process involves diverse phosphorylation-
dependent sensitization and proton-activation/potentiation of
TRPV1 channel activity by a variety of pro/inflammatory mediators
(Hucho and Levine, 2007; Patapoutian et al., 2009; Gold and Geb-
hart, 2010; Kuner, 2010; Ren and Dubner, 2010). Here we demon-
strate that CNP induces acute sensitization of TRPV1 channel
activity through a non-canonical Gi–G-mediated downstream
activation of PKC and phosphorylation of the channel protein, re-
sulting in enhanced nociceptor firing.We also show thatCNP injec-
tion leads to the development of thermal hyperalgesia that is
dependent on G/ signaling and TRPV1.
Materials and Methods
All experiments involving the use of mice and the procedures followed
therein were approved by the University of Iowa Institutional Animal
Care andUse Committee and in strict accordance with theNIHGuide for
the Care and Use of Laboratory Animals. Every effort was made to mini-
mize the number of mice used and their suffering.
Primary cultures of mouse DRG neurons. DRGs were isolated from adult
C57BL/6 mice of both TRPV1/ and TRPV1/ genotypes and cultured
on poly-L-ornithine- and laminin-coated glass coverslips, as described pre-
viously (Schnizler et al., 2008). Briefly, isolated DRGs were digested with
collagenase for 20 min followed by neutralization, centrifugation, and tritu-
ration before further digestion with pronase for 10 min. Cells were then
pelleted by centrifugation and resuspended in DMEM (Invitrogen) supple-
mented with 10% fetal bovine serum, before additional trituration with
fire-polished glass Pasteur pipettes. Neurons were plated onto poly-L-
ornithine- and laminin-coated glass coverslips. After 90 min incubation at
37°C in a 5% CO2 incubator, the culture media was changed to TNB media
supplemented with protein–lipid complex (Biochrom) and cultured
therein, as described previously (Constantin et al., 2008). Cultured DRG
neurons were used in electrophysiological, immunocytochemical, and bio-
chemical experiments within 1–4 days of in vitro (DIV) culturing.
Site-directed mutagenesis and transfection of human embryonic kidney
293T cells. Mutagenesis of rat TRPV1 cDNA was performed on the
pcDNA3–rTRPV1 plasmid (generously provided by Dr. David Julius,
University of California, San Francisco, San Francisco, CA) using the
quick-change site-directed mutagenesis kit (Agilent Technologies). We
generated the rTRPV1–S502A, rTRPV1–T704A, rTRPV1–S800A, and
rTRPV1–S502A/T704A/S800A triple PKC phosphorylation site mutant
constructs using the pcDNA3–rTRPV1-S502A/S800A plasmid as the
template (generously provided by Dr. Carla Nau, University of Erlan-
gen–Nuremberg, Nuremberg, Germany). Human embryonic kidney
293T (HEK293T) cells were cultured in DMEM with 1 GlutaMAX
(both from Invitrogen) and 10% fetal bovine serum (HyClone) and
maintained at 37°C in a humidified incubator with 5% CO2. Cells were
transiently transfected with wild-type (WT) or PKC site mutant TRPV1
plasmids (0.5 g) along with the reporter plasmid (0.5 g peGFPc1;
Clontech), with or without the pCMV–Sport6–hNPR-C plasmid (0.5
g; Open BioSystems) using Lipofectamine2000 (Invitrogen) reagent, as
per the instructions of the manufacturer. Transfected cells were used for
electrophysiological experiments within 36–48 h.
Calcium imaging. Functional Ca2 imaging on cultured mouse DRG
neurons (2–3 DIV) was performed as described previously (Schnizler et
al., 2008). Neurons on glass coverslips were incubated at room temper-
ature (22°C) for 30 min with 2 M of the AM form of the Ca2-sensitive
dye fura-2 (Invitrogen). The coverslip was then placed in the recording
chamber mounted on the stage of an inverted IX-71 microscope (Olym-
pus) and washed for 10 min before the experiment began. Fluorescence
was alternately excited at 340 and 380 nm (both 12 nm bandpass) using
the Polychrome IV monochromator (T.I.L.L. Photonics), via a 10 or
20 objective [numerical aperture (NA) 0.75; Olympus]. Emitted fluo-
rescence was collected at 510 (80) nm using an IMAGO CCD camera
(T.I.L.L. Photonics). Pairs of 340/380 nm images were sampled at 0.2 Hz.
Bath application of capsaicin (15 s) was performed twice with a 5 min
interval, and NPs, prostaglandin E2 (PGE2), and bradykinin (BK) were
applied during this interval. The fluorescence ratio (r  F340/F380) was
converted to [Ca2]i, as described previously (Schnizler et al., 2008).
Data were processed and analyzed using TILLvisION 4.0.1.2 (T.I.L.L.
Photonics) and Origin 7.0 (OriginLab) software and presented as
mean  SEM. All the Ca2 imaging experiments with or without NP/
PGE2/BK treatments were performed in triplicate across three different
batches of mouse DRG neuron cultures.
Electrophysiology and data analyses. Currents were recorded from
small/medium-diameter cultured mouse DRG neurons (1–4 DIV) and
transfected HEK293T cells at room temperature with whole-cell config-
uration of the patch-clamp technique. The holding potential was 70
mV. Patch pipettes were pulled fromborosilicate glass tubes (TW150F-4;
World Precision Instruments) and heat polished at the tip using a micro-
forge (MF200; World Precision Instruments) to give a resistance of 3–6
M when filled with the pipette solution consisting of the following (in
mM): 5 NaCl, 140 KCl, 1 MgCl2, 10 HEPES, and 10 EGTA, pH 7.3. Cells
were bathed in extracellular buffer consisting of the following (in mM):
140 NaCl, 5 KCl, 0.1 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.4
(or pH 6.8 or 6.4 for proton-activation experiments). Low extracellular
Ca2 concentration was used to minimize the Ca2-dependent desen-
sitization of TRPV1 currents (Koplas et al., 1997;Mohapatra et al., 2003).
For recordings in neurons, 1 M tetrodotoxin was added to the extracel-
lular buffer to block fast-activatingNav currents. For extracellular buffers
used in experiments with proton-activated currents (pH 5.8, 5.4, and
4.8), HEPES was substituted with MES. All the activators/drugs were
diluted in the extracellular buffer, from a stock solution, to achieve final
concentrations. All control and agonist/drug-containing extracellular
buffers were applied locally onto the cells under recording, with a sepa-
rate Teflon tubing-connected glass multiple-barrel perfusion system.
Currentswere recordedwith anAxopatch 200Bpatch-clamp amplifier
connected to a Digidata 1440A data acquisition system (Molecular De-
vices), with a sample rate of 2 kHz and filtering at 1 kHz. pClamp 10
software (Molecular Devices) was used for the acquisition of currents,
and Clampfit 10 (Molecular Devices) and Origin 7.0 (Origin Lab) soft-
ware were used for the analysis of currents and preparing traces/figures.
Data are presented as means  SEM or fitted value  SE of the Hill
equation fit for the pH dose–response relationship.
Capsaicin- and proton-induced action potential (AP) firings in small/
medium-diameter cultured mouse DRG neurons were recorded under the
current-clamp mode at room temperature following similar procedures
used in cultured hippocampal neurons (Mohapatra et al., 2009). Neurons
were bathed in extracellular buffer containing the following (in mM): 140
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.3. The
pipette solutioncontained the following (inmM): 5NaCl, 140KCl, 1CaCl2,1
MgCl2, 10HEPES, 5 EGTA, 3Na-ATP, and 0.3Mg-GTP, pH7.3. The num-
ber of APs elicited on each capsaicin and acidic pH treatment episodes of
similar durationwere counted to determine the nociceptor firing frequency.
RT-PCR. Total RNA was isolated from cultured mouse DRG neurons
(2–4DIV) andHEK293T cells using TRIzol reagent (Invitrogen), treated
with DNase-I for 30 min at 37°C, followed by inactivation at 65°C, and
subsequently reverse transcribed into cDNA using a SuperScript III RT-
PCR kit (Invitrogen), as per manufacturer’s instructions. Next, individ-
ual PCR reactions were performed using these cDNAs and Pfu DNA
polymerase (Agilent Technologies) with specific primer sets for NPR-A
(forward, 5-TTCTCCCTCTGGGATATGGATC-3; and reverse, 5-AT
GCGTTTACGGTTCACACG-3), NPR-B (forward, 5-CAGAACACAA
CCTGAGCTATGC-3; and reverse, 5-CAGCAATAAGGTTCATCAGG
G-3), NPR-C (forward, 5-ACAATTTCGACGAGACCAAAG-3; and
reverse, 5-CGCCTCTCAATGGTTATTCTG-3), and GAPDH (forward, 5-
TCAGCAATGCATCCTGCAC-3; and reverse, 5-CCAGGAAATGAGCT-
TGACAAAG-3) for 30 cycles. The amplified PCR products were size
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fractionated in 0.7%agarose gel electrophoresis and stainedwith ethidiumbro-
mide, to visualize the DNA bands and verify the respective predicted product
sizes.
Assay for intracellular cGMPproduction inDRGneurons.Quantificationof
ANP/BNP/CNP-induced intracellular cGMP production in freshly isolated
mouse DRG neurons was performed using a direct ELISA kit (Enzo Life
Sciences) following the instructions of themanufacturer. Briefly, freshly iso-
lated and dissociated DRG neurons from adult male mice were treated with
individual NPs (15 min at 37°C) and subjected to lysis and subsequent de-
termination of intracellular cGMP concentration. The protein concen-
trations in cell lysates were determined by the BCA method (Pierce).
Intracellular cGMP concentrations were expressed as picomoles of cGMP
per microgram of protein. Three independent experimental replicates were
generated from three different batches of mouse DRG neurons.
Immunostaining of DRG sections and cultured DRG neurons. Adult
male C57BL/6 mice were killed, and L4–L6 lumbar DRG pairs were then
dissected out from these animals and postfixed with 4% paraformalde-
hyde plus 5% picric acid [in 0.1 M phosphate buffer (PB)] overnight at
4°C before being transferred into 15% sucrose in 0.1 M PB for an addi-
tional incubation overnight at 4°C. Twenty-five-micrometer-thick sec-
tions of fixedDRG tissue were obtained using a cooled cryostat (CM3050
S; Leica Microsystems), as detailed previously (Shepherd and Mohapa-
tra, 2012). Free-floating DRG tissue sections were washed in a 48-well
tissue culture plate with 0.1 M PB, before being incubated with blocking/
permeabilization solution (10% goat serum plus 0.3% Triton X-100 in
0.1 M PB) at 4°C for 60 min. The sections were then incubated with rabbit
polyclonal anti-NPR-C antibody (10 g/ml; Abgent) along with mouse
monoclonal anti-calcitonin gene-related peptide (CGRP) (1 g/ml) or
mouse monoclonal anti-neurofilament-200 (NF-200) (1 g/ml; both
from Sigma) or mouse monoclonal anti-TRPV1 (5 g/ml; clone N221/
17; NeuroMab) antibody in blocking solution overnight at 4°C. After
washing in blocking solution (three times for 10 min each at room tem-
perature with vigorous agitation), the sections were incubated with goat
anti-mouse IgG Alexa Fluor-555 and goat anti-rabbit Alexa Fluor-488-
conjugated (1:1000 each; Invitrogen) secondary antibodies for 180 min
in blocking solution at 4°C protected from light. The sections were sub-
sequently washed first with 10% goat serum in 0.1 M PB for 5 min, with
0.1 M PB for 5 min, and finally with 0.05 M PB for 5 min (all at room
temperature with vigorous agitation). Finally, the sections were carefully
transferred onto glass slides and covered with glass coverslips with Pro-
Long Gold antifade reagent (Invitrogen), as described previously (Shep-
herd and Mohapatra, 2012). Confocal fluorescence images of mounted
DRG tissue sections were taken using a BX61WI microscope equipped
with the Fluoview 300 laser-scanning confocal imaging system (Olym-
pus) with a 10 objective (NA 0.25; Olympus).
Fluorescence immunostaining of cultured mouse DRG neurons were
performed following standardized procedures detailed previously (Mo-
hapatra et al., 2008). Control and drug-treated cultured mouse DRG
neurons (2–3 DIV) were washed in Dulbecco’s PBS, followed by 30 min
fixation with 3% paraformaldehyde containing 4% sucrose at 4°C with
slow agitation. Neurons were washed three times for 5 min each with
Tris-buffered saline (TBS) and then incubatedwith the blocking solution
(4% fat-free milk powder in TBS with 0.1% Triton X-100) at room
temperature for 45–60 min on a medium-speed rocking platform. Cells
were incubated with rabbit polyclonal anti-NPR-C (5g/ml; Santa Cruz
Biotechnology) and mouse monoclonal anti-PKC (5g/ml; BD Biosci-
ence) antibodies diluted in blocking solution at room temperature for
45–60 min. After washing with blocking solution (three times for 5 min
each at room temperature), neurons were incubated with goat anti-
mouse IgG Alexa Fluor-488-conjugated and goat anti-rabbit Alexa
Fluor-555-conjugated (1:2000; Life Technologies) secondary antibodies
for 45–60 min in blocking solution at room temperature protected from
light. Coverslips were subsequently washed with TBS (four times for 5
min each at room temperature) and mounted onto glass slides. Confocal
fluorescence images of neurons were captured using a BX61WI micro-
scope equipped with the Fluoview 300 laser-scanning confocal imaging
system with a 10 objective (NA 0.25; Olympus). Quantification of
cellular PKC distribution and translocation in neurons was performed
using NIH Image J software as described previously (Cesare et al., 1999;
Hucho et al., 2005). From the determined PKC signal intensity across
the line on every neuron, the peak intensity in the outer 10% of the cell
diameter was taken as the peripheral, and the peak intensity in the inner
90% of the cell diameter was taken as the cytoplasmic localization. Ratio
of the peak peripheral versus cytoplasmic intensity in each neuron was
calculated, with a higher ratio indicating more peripheral localization of
PKC. In addition, the number of individual small/medium-diameter
cultured DRG neurons with PKC immunostaining (both peripheral
translocation and diffused cytoplasmic distribution) were counted for
each treatment group (	500 neurons for each group) in a blinded man-
ner. These data were quantified and plotted as percentage of neurons
with peripheral PKC translocation with different drug treatment con-
ditions. All immunostaining experiments were repeated four times on
four different batches of mouse DRG neuron cultures.
Immunoprecipitation and immunoblotting. Coimmunoprecipitation of
NPR-B and NPR-C with G-protein -subunits from cultured mouse DRG
neurons was performed following previously standardized protocols (Mo-
hapatra et al., 2008; Schnizler et al., 2008). Briefly, cultured mouse DRG
neurons (2–3 DIV) were lysed with ice-cold lysis buffer consisting of 0.02 M
Tris-HCl, pH 8.0, 0.15 M NaCl, 0.001 M NaF, 0.002 M EDTA, 0.001 M PMSF,
1 protease inhibitor cocktail (leupeptin, aprotinin, antipain, and
benzamidine-HCl), and 1% Triton X-100, for 30 min at 4°C on a rotator,
followedbycentrifugationat12,000g for10minat4°Ctopellet thedebris.
The lysateswere then incubatedwith rabbit polyclonal anti-NPR-B- or anti-
NPR-C- (both Abgent) or rabbit polyclonal anti-HA antibody-tagged re-
combinant protein A-Sepharose beads (Pierce) suspended in lysis buffer
containing BSA (0.2mg/ml final) at 4°C for 2 h on a rotator. The beadswere
then centrifuged at 3500 g for 5 min at 4°C and washed seven times with
the lysis buffer containing BSA, and the supernatant was discarded after the
final wash. Immunoprecipitated proteins were released from the beads by
boiling with an equal bead volume of 0.05% SDS and 2-mercaptoethanol-
containing gel-loading buffer for 5 min and subsequently size fractionated
on 10% SDS-PAGE gels, followed by transfer onto nitrocellulose mem-
branes (Bio-Rad).Membraneswere probedwith rabbit polyclonal anti-Gq
(1:200; Santa Cruz Biotechnology) or anti-Gi antibodies (1:200; Cell Sig-
naling Technology) or mouse monoclonal anti-Gs antibody (1:200; clone
N192/12; NeuroMab) and subsequently with goat anti-mouse or anti-
rabbit IgG–HRP secondary antibodies (1:10,000; Antibodies Inc.). Im-
munoreactive proteins on membranes were developed with enhanced
electrochemiluminescence-plus reagent (ECL-Plus; PerkinElmer Life
and Analytical Sciences), and the signals were captured on x-ray film
(Kodak-Biomax; Carestream Health).
For ERK phosphorylation assays, cultured mouse DRG neurons (2 DIV)
were treated with either vehicle or 100 nM CNP, and cell lysates were pre-
pared 30 min after treatment using the same lysis buffer and methods as
mentioned above. Lysates were then run on 10%SDS-PAGE gels and trans-
ferred onto nitrocellulose membranes. Membranes were probed with either
rabbitpolyclonal anti-ERK1/2(1:1000;Cell SignalingTechnology)ormouse
monoclonal anti-phospho-ERK1/2 (1:500; BD Bioscience) antibody, along
with the mouse monoclonal anti-GRP75 antibody (1:1000; clone N52A/42;
NeuroMab), and subsequently with goat anti-mouse or anti-rabbit IgG–
HRP secondary antibodies (1:10,000; Antibodies Inc.). Immunoreactive
proteins on membranes were developed with enhanced ECL-Plus re-
agent (PerkinElmer Life and Analytical Sciences), and the signals were
captured on x-ray film (Kodak-Biomax). All the immunoprecipita-
tion and immunoblotting experiments were repeated three times on
three different batches of mouse DRG neuron cultures.
Chemicals and reagents. Purified recombinant human/rodent ANP,
BNP, and CNP, PTX, PGE2, BK, collagenase, and Pronase were pur-
chased from EMD Chemicals and Phoenix Pharmaceuticals; the fura-2
AM was from Invitrogen; 8-Br-cGMP and 8-pCPT-cGMP were from
Enzo Life Sciences; capsaicin and the TRPV1 antagonist AMG9810 [(E)-3-
(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide]
were fromSigma; theG inhibitor galleinwas fromAcrosOrganics; PLC
inhibitor U73122 (1-[6[[(17)-3-methoxyestra-1,3,5(10)-trien-17-yl]ami-
no]hexyl]-1H-pyrrole-2,5-dione), PKC inhibitor bisindoylmelimide-I
(BIM), protein kinase A (PKA) inhibitor KT5720 [(9S,10R,12R)-
2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1
H-diindolo[1,2,3-fg:3,2,1-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-
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carboxylicacid hexyl ester], PKG inhibitor KT5823 [(9S,10R,12R)-2,3,9,
10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-
diindolo[1,2,3-fg:3,2,1-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carbox-
ylic acid methyl ester], and PKC activator phorbol 12-myristate 13-acetate
(PMA)were fromTocris Bioscience. All other chemicals used in this study
were purchased from Sigma, Bio-Rad, Roche Applied Science, and
Thermo Fisher Scientific. All NeuroMab antibodies were purchased from
the University of California, Davis/National Institutes of Health NeuroMab
Facility through Antibodies Inc.
Behavioral assessment of inflammatory thermal hyperalgesia. Adult
male C57BL6/J mice of both TRPV1/ and TRPV1/ genotypes were
housed as five mice per cage and maintained on a 12 h light/dark cycle
(dark cycle beginning at 6:00 P.M.) with access to food and water ad
libitum. Animals were acclimated to the testing environment for 2 days
before testing for 30 min each and on the day of behavioral testing for 30
min by placing them in individual Plexiglas chambers situated on a glass
surface maintained at thermo-neutral temperature (IITC Life Science).
Nociceptive thermal sensitivity on each hindpawwasmeasured by focus-
ing a high-intensity beam of light on the plantar surface, and the time
required for the mouse to withdraw its hindpaw from the thermal stim-
ulus was recorded using a programmable digi-
tal counter (IITC Life Science) and was termed
the paw-withdrawal latency (PWL). The beam
intensity was adjusted to elicit baseline PWL of
10–12 s. The cutoff timewas 20 s, at which time
the test was terminated to prevent tissue injury
and the mouse paw was assigned this latency.
Average PWL from two readings for each hind-
paw were taken for analysis.
After baseline PWL measurements, animals
were microinjected with either saline or differ-
ent concentrations of CNP (10l of 10 nM, 100
nM, 500 nM, and 10 M stock) into the plantar
surface of the right hindpaw (ipsilateral) via a
33 gauge stainless steel injector needle coupled
to a Hamilton syringe, and subsequent PWLs
were measured at 30 min, 2 h, 4 h, 6 h, and 24 h
after injection. In a separate groups of ani-
mals, gallein [100 mg/kg, i.p.; (Lehmann et
al., 2008)] or AMG9810 [30 mg/kg, i.p.
(Gavva et al., 2005)] were administered 30
min before saline/CNP injections. At least
three replicates of each treatment group were
performed. The individual performing the
behavioral testing was blinded to the site and
details of drug injections, as well as to mouse
genotype.
Statistical analyses. Data are presented as
mean  SEM. For Ca2 imaging, Kruskal–
Wallis test with Dunn’s correction was used to
test the effects of different NPs, PGE2, and BK
on potentiation of capsaicin-induced Ca2
flux. For cGMP assays, Student’s t test was used
to test the effects of different NPs on cGMP
production. For electrophysiological experi-
ments, one-way ANOVA with post hoc Dun-
nett’s correction was performed to test the
statistical significance of the effects of different
drug treatments on NP-induced potentiation
compared with control (vehicle). Statistical
analysis of data for PKC translocation assays,
as well as for the behavioral assessments of
thermal hyperalgesia, were performed by one-
wayANOVAwith post hocBonferroni’s correc-
tion to compare the differences between
various treatments. p
 0.05 in each set of data
comparisons were considered statistically sig-
nificant. All statistical analyses were conducted
using SPSS 19 software (IBM).
Results
NPs potentiate capsaicin responses in mouse DRG neurons
We first examined the effects of NPs on the activity of TRPV1 in
small/medium-diameter cultured mouse DRG neurons by mon-
itoring TRPV1-mediated [Ca2]i responses, as described previ-
ously (Schnizler et al., 2008). Two consecutive applications of
capsaicin (50 nM for 15 s, with 5 min washing in between) re-
sulted in desensitization/tachyphylaxis of [Ca2]i for the second
application, with a ratio of 0.35 0.1 for second/first capsaicin-
induced [Ca2]i (n 14; Fig. 1A,B). However, extracellular ap-
plication of ANP or CNP (50 and 500 nM each for 5 min) to DRG
neurons resulted in significant potentiation of [Ca2]i responses
induced by the second capsaicin application, with peak Ca2
ratios of 4.67 1.17 (n 17) and 2.22 0.49 (n 18) for 50 and
500 nM ANP, respectively, and 3.54  0.8 (n  15) and 17.2 
5.66 (n  9) for 50 and 500 nM CNP, respectively (Fig. 1A,B).
Conversely, BNP application (50 and 500 nM for 5 min) did not
Figure 1. Natriuretic peptides ANP and CNP, but not BNP, sensitize TRPV1 channel activity in mouse DRG neurons. A, Repre-
sentative traces of Ca 2 flux in small/medium-diameter cultured mouse DRG neurons in response to two successive applications
of capsaicin (50 nM, 15 s, arrowheads),with the continuous extracellular perfusion of ANP, BNP, and CNP (50 nM each) or vehicle for
5 min between two capsaicin applications. B, Quantification of Ca 2 flux measurements from Ca 2 imaging experiments as
shown in A, with extracellular perfusion of 50 and 500 nM ANP, BNP, CNP, or BK, and 500 nM or 5M PGE2. Data are presented as
meanSEMof the ratio of secondversus first Ca 2peak;n values are shown inparentheses for each treatmentgroup. *p
0.05,
**p
0.01, and***p
0.001, significantlydifferent (NS,not significant) comparedwithvehicle (Kruskal–Wallis testwithDunn’s
correction). C, Representative traces of whole-cell TRPV1 currents in small/medium-diameter cultured mouse DRG neurons in
response to four successive applications of capsaicin (50 nM for 5 s; with 1min interval), with continuous extracellular perfusion of
ANP, BNP, or CNP (10 nM) or vehicle (extracellular buffer) after the second capsaicin application. D, Quantification of capsaicin-
activated TRPV1 currents (ICap) for experiments as shown in C. Data are presented as mean SEM of fold increase in peak ICap
normalized to second ICap; n values are given for each treatment group. *p
 0.05, significantly different compared with the
respective ICap for vehicle group (one-way ANOVA with post hoc Dunnett’s correction).
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show any significant potentiation of
[Ca2]i responses to the second capsaicin
application [ratios 0.79  0.28 (n  9)
and 0.53 0.1 (n 12), respectively; Fig-
ure 1A,B]. We also compared the poten-
tiating effects of NPs with two major
inflammatory mediators, PGE2 and BK.
Extracellular application of PGE2 (5 M)
and BK (50 and 500 nM) resulted in signif-
icant potentiation of [Ca2]i responses
induced by the second capsaicin applica-
tion, with peak Ca2 ratios of 4.23 1.48
(n  12), 9.52  6.16 (n  10), and
11.33 6.26 (n 9) for 5M PGE2, 50 nM
BK, and 500 nM BK, respectively (Fig. 1B).
However, application of 500 nM PGE2 did
not lead to any significant potentiation of
[Ca2]i responses to the second capsaicin
application [ratio 2.12  0.73 (n  16),
respectively; Fig. 1B].
Next,weperformedwhole-cellpatch-
clamp analysis to verify NP-mediated
sensitization of TRPV1 channel activity
suggested by our Ca2 imaging studies.
Application of ANP and CNP, but not
BNP (10 nM each), led to significant po-
tentiation of capsaicin-activated (50 nM,
5 s) inward currents (ICap) in small/
medium-diameter cultured mouse DRG
neurons. There were 4.31  1.44-fold
(n  9) and 4.87  0.85-fold (n  16)
increases in the third ICap for ANP and
CNP treatment groups, respectively, com-
pared with a 1.6 0.53-fold (n 10) in-
crease in the vehicle treatment group, and
a 5.89  1.72- and 4.72  0.67-fold in-
crease in the fourth ICap for ANP and CNP
treatment groups, respectively, compared
with a 1.14 0.25-fold increase in the ve-
hicle treatment group (Fig. 1C,D). We
further determined the NP dose–response
relationships for the potentiation of
TRPV1 channel activity. Increasing con-
centrations of ANP andCNP (1, 3, 10, 30, and 100 nM) resulted in
enhanced potentiation of ICap, with saturation being achieved at
30 nM, whereas BNP did not induce any significant potentiation
for all concentrations (data not shown). Together, these data
indicate that ANPandCNP, but not BNP, significantly potentiate
TRPV1 channel activity in a dose-dependent manner.
Noncanonical NPR-C/GPCR signaling underlies the NP-
induced potentiation of TRPV1 channel activity
Previous reports have shown the expression of NPR-A/B in ro-
dent DRG neurons (Zhang et al., 2010). We also performed RT-
PCR with specific primer sets for NPR-A/B/C and show that all
three NPR subtypes are expressed in adult mouse DRG neurons
(Fig. 2A). Activation of NPR-A by A/BNP and of NPR-B by CNP
has been shown to increase intracellular cGMP production and
subsequent activation of PKG (Pandey, 2005b; Potter et al.,
2006). Indeed, application of ANP, BNP, or CNP (50 nM, 15min)
to mouse DRG neurons led to increased intracellular cGMP pro-
duction (0.68  0.5, 1.89  0.26, 1.96  0.29, and 2.89  0.71
pmol cGMP/g protein for untreated, ANP-, BNP-, and CNP-
treated neurons, respectively), as determined by ELISA (Fig. 2B).
We next determined whether elevated levels of intracellular
cGMP in response to NP treatment underlie TRPV1 channel
sensitization. Direct perfusion of two membrane-permeable
cGMP analogs, 8-Br-cGMP (100 M) and 8-pCPT-cGMP (200
M), did not significantly potentiate ICap in DRG neurons
[0.82  0.11- and 0.78  0.15-fold increase in third and fourth
ICap, respectively, for 8-Br-cGMP treatment group (n  6), and
1.26 0.05- and 1.25 0.1-fold increase in third and fourth ICap,
respectively, for 8-pCPT-cGMP treatment group (n  4); Fig.
2C]. Furthermore, pretreatment of neurons with a PKG inhibitor
(KT5823, 500 nM) did not inhibit CNP-induced potentiation of
peak ICap [3.83 0.44- and 4.69 1.21-fold increase in third and
fourth ICap, respectively (n 7); Fig. 2C]. These data suggest that
the canonical cGMP–PKG signaling pathway is not involved in
CNP-induced sensitization of TRPV1; therefore, we next tested
whether other protein kinases are involved in CNP-induced po-
tentiation of ICap. TRPV1 channel protein is a target for direct
phosphorylation by PKA and PKC, which results in potentiation
of channel activation by different agonists (Premkumar and
Figure 2. Expression of NP receptors and role of downstream cGMP signaling in mouse DRG neurons underlying CNP modula-
tion of TRPV1 channel activity. A, All three NP receptors (NPR-A, NPR-B, and NPR-C) are expressed in DRG neurons. Representative
RT-PCR analysis of NPR expression in culturedmouseDRGneuronswith primers specific for NPR-A, NPR-B, andNPR-C, aswell as for
GAPDH as the housekeeping gene. B, ELISA-based quantification of intracellular cGMP levels in isolated mouse DRG neurons after
ANP, BNP, or CNP treatment (100 nM for 30 min). Data are presented as mean SEM (n 3). *p
 0.05, significantly different
comparedwith the vehicle group (Student’s t test).C, CNP-induced sensitization of TRPV1 is dependent onPKC, but not cGMP–PKG
or PKA, signaling. Top panel shows representative traces of TRPV1 currents in small/medium-diameter cultured mouse DRG
neurons in response to four successive applications of capsaicin (50 nM for 5 s; with 1 min interval), with continuous extracellular
perfusion of 8-Br-cGMP (100M) after the second Icap. Bottom panel shows the quantification of ICap with indicated drug treat-
ments [100M 8-Br-cGMP, 200M 8-pCPT-cGMP, 10 nM CNP, 10 nM CNP 500 nM KT5823 (PKG inhibitor), 10 nM CNP 400 nM
KT5720 (PKA inhibitor), and10nMCNP1MBIM (PKC inhibitor)]. Peak ICap amplitudes arenormalized to second ICap application
of the respective vehicle or treatment groups, and the data are presented as mean SEM of fold-increase in ICap compared with
second ICap (respective n values are shown in the figure). *p
 0.05, significantly different compared with the vehicle group
(one-way ANOVA with post hoc Dunnett’s correction).
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Ahern, 2000; Bhave et al., 2002, 2003; Numazaki et al., 2002;
Mohapatra and Nau, 2003, 2005). Thus, we next tested whether
NPmodulation of TRPV1 channel activity ismediated by PKAor
PKC. Pretreatment of neuronswith a PKC inhibitor (BIM, 1M),
but not with a PKA inhibitor (KT5720, 400 nM), attenuated the
CNP-induced potentiation of peak ICap [0.89 0.15- and 0.56
0.19-fold increase in third and fourth ICap, respectively, for CNP
 BIM treatment group (n 4), and 3.87
 1.33- and 6.23  2.4-fold increase in
third and fourth ICap, respectively, for
CNP KT5720 treatment group (n 8);
Fig. 2C]. These results indicate that CNP
potentiates TRPV1 activity via a PKC-
dependent pathway, leading us to further
explore the CNP signaling through
NPR-C that is coupled to the PKC activa-
tion in DRG neurons.
Although NPR-C has been reported to
serve as the clearance receptor for NPs,
several reports have suggested that
NPR-C can functionally couple to the Gi
subunit, which in turn produces G-
mediated activation of PLC, PIP2 hydro-
lysis, and PKC activation (Levin, 1993;
Murthy and Makhlouf, 1999; Murthy et
al., 2000; Anand-Srivastava, 2005). Using
immunohistochemical staining of adult
mouse lumbar DRGs, we found that
NPR-C is expressed in most neurons, in-
cluding those that express the A-fiber
marker NF200 and those that express the
peptidergic C-fiber marker CGRP (Fig.
3A). Almost all the TRPV1-positive neu-
rons were also positive for NPR-C (Fig.
3A). Next, we determined the specific type
of G subunits that couple to NPR-C in
mouse DRG neurons. Immunoprecipita-
tion of NPR-C, but not NPR-B, specifi-
cally coprecipitated the Gi but not Gq
or Gs subunits in mouse DRG neurons
(Fig. 3B). Activation of a number of Gi-
coupled GPCRs, including NPR-C, has
been shown to activate PKC via the disso-
ciation of G subunits from Gi during
receptor activation and subsequent acti-
vation of PLC (Murthy and Makhlouf,
1999; Murthy et al., 2000; Shi et al., 2003;
Anand-Srivastava, 2005; Chen et al., 2005;
Pandey, 2005b; Sabbatini et al., 2007). Ac-
tivation of Gi/o-coupled GPCRs also
leads to the activation of MAPK/ERK and
PLC–DAG–PKC signaling cascades.
Therefore, we next determined whether
CNP was capable of activating these sig-
naling cascades in DRG neurons. CNP
treatment of cultured mouse DRG neu-
rons (100 nM, 30 min) increased phos-
phorylation of ERK1/2, without any
change in total ERK1/2 levels (Fig. 3C).
Because CNP-induced potentiation of
TRPV1 activity was attenuated by inhibi-
tion of PKC (Fig. 2C), we next determined
whether CNP treatment could activate
PKC by monitoring its translocation to the plasma membrane of
DRG neurons as a readout of PKC activation (Cesare et al., 1999;
Hucho et al., 2005). We focused on PKC, because this isoform is
known to phosphorylate and sensitize TRPV1 upon activation by
capsaicin and heat (Cesare et al., 1999; Premkumar and Ahern,
2000; Vellani et al., 2001; Numazaki et al., 2002; Bhave et al.,
2003). Under control conditions, PKC was evenly distributed
Figure 3. Expression of NPR-C and characterization of downstream intracellular signaling originating from CNP treatment in
mouse DRG neurons. A, Representative photomicrographs depicting immunohistochemical staining of mouse L4–L6 DRG sec-
tions, indicating NPR-C expression in NF200-positive large-diameter neurons, as well as in CGRP- and TRPV1-positive small/
medium-diameter neurons. Scale bar, 50 m. B, Immunoprecipitation of Gi subunits, but not Gq or Gs subunits, with
anti-NPR-C antibody, but notwith anti-NPR-B antibody, in culturedmouse DRGneurons. Anti-HA antibodywas used as a negative
control in immunoprecipitation reactions. The immunoprecipitates, along with the input DRG lysates, were size fractionated in
SDS-PAGE and immunoblotted with specific antibodies against Gi, Gq, and Gs subunits. C, Western/immunoblot analysis of
ERK1/2 phosphorylation induced by CNP treatment of cultured mouse DRG neurons (100 nM for 30 min). Blots were probed with
phospho-ERK1/2 and total ERK1/2, as well as with GRP75 as loading control. IB, Immunoblot; IP, immunoprecipitation.
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throughout the cytoplasm of mouse DRG neurons (Fig. 3D).
CNP treatment (100 nM, 5min) led to translocation of the bulk of
PKC immunoreactivity to the cell plasma membrane, as was
similarly observed during treatment with the potent PKC activa-
tor PMA (200 nM, 2 min; Fig. 4A,C,D). Pretreatment of neurons
with PTX (100 ng/ml for18 h), a potent inhibitor of Gi–G
subunit dissociation during receptor activation, led to the atten-
uation of PKC translocation to the cell plasma membrane in
response to CNP but not to PMA treatment (Fig. 4B--D). These
results suggest that NPR-C, but not NPR-B, couples to Gi sub-
unit in mouse DRG neurons to activate MAPK and PKC via
Gi–G-mediated downstream signaling. Because it has been
suggested that the affinities of CNP and ANP for Gi-coupled
NPR-C are higher than that of BNP (He et al., 2001; Anand-
Srivastava, 2005), it is possible that distinct NP-mediated signal-
ing pathways prevail in different tissues/cells based on the specific
expression of individual NP receptor subtypes.
CNP potentiates acid-induced TRPV1 channel activation
Protons (H) are well-known endogenous activators of TRPV1,
and the H concentration is substantially increased at sites of
tissue injury or inflammation (Dray and Read, 2007; Hucho and
Levine, 2007; Basbaum et al., 2009; Gold and Gebhart, 2010;
Kuner, 2010). Therefore, we examined whether CNP could po-
tentiate proton-induced inward currents (IpH) in small/medium-
diameter mouse DRG neurons. In these experiments, we used a
protocol similar to that shown in Figure 1C, except the cells were
stimulated with acidic pH extracellular buffer instead of capsai-
cin. Application of extracellular buffer with pH 6.4 resulted in
two types of inward currents in small/medium-diameter cultured
mouse DRG neurons. The first type was characterized by a rap-
idly activating inward current component followed by a sus-
tained inward current (Fig. 5A, left). These neurons also
exhibited capsaicin-induced inward currents that were elicited
with the application of capsaicin (100 nM, 5 s) after the fourth
Figure 4. CNP treatment leads to translocation of PKC in mouse DRG neurons. Immunocytochemical analysis of PKC translocation to the cell periphery in cultured mouse DRG neurons upon
treatmentwithCNP (100nM for 5min) andPMA(200nM for 2min; as apositive control) comparedwith vehicle (DMSO) treatment. Representativephotomicrographsof neurons immunostainedwith
anti-NPR-C (red) and anti-PKC (green) antibodies under control (A) and PTX (100M, 24 h) (B) treatment conditions. Right panels for each image sets are magnified views of cells marked with
respective rectangular white boxes, and the line graphs show the PKC distribution profile (NIH Image J) within respective cells across the drawn white lines. The high-intensity peak signals near
both ends of the path described by the line denote increased PKC translocation to the cell plasmamembrane. C, Quantification of PKC translocation to the cell periphery under different treatment
conditions (for details of analysis, see Materials and Methods). Data are presented at mean SEM of the peak intensity ratios (peripheral/cytoplasmic; n 25 cells for each treatment condition,
from four independent cultures).D, Quantification of number of DRGneuronswith PKC translocation to the cell periphery under different treatment conditions. Data are presented atmean SEM
of the percentage of cells with increased PKC staining intensity at the cell periphery (n	 500 neurons for each treatment group, from 4 independent cultures). For C, D, *p
 0.05 and ***p

0.001, significantly different compared with their respective vehicle groups; #p
 0.05 and ###p
 0.001, significantly different compared with CNP treatment in control group (one-way ANOVA
with post hoc Bonferroni’s correction).
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IpH6.4. The other type displayed rapidly activating and rapidly
inactivating inward currents (Fig. 5A, right), and these neurons
did not exhibit any response to capsaicin (100 nM, 5 s). CNP
application (10 nM) strongly potentiated the peak IpH6.4 [6.58
1.07- and 9.87  2.43-fold increase in third and fourth IpH6.4,
respectively (n  31)] in capsaicin-sensitive neurons but not in
capsaicin-insensitive neurons [1.33 0.05- and 1.08 0.14-fold
increase in third and fourth IpH6.4, respectively (n  6); Fig.
5A,C]. These data indicate that CNP potentiates IpH6.4 only in
DRG neurons that express TRPV1. To further confirm our find-
ings, we evaluated CNP potentiation of IpH6.4 in cultured small/
medium-diameter DRG neurons from
TRPV1/ mice and found that CNP did
not potentiate peak IpH6.4 in these neurons
[1.43 0.28- and 1.65 0.37-fold increase
in third and fourth IpH6.4, respectively (n
9); Fig. 5B,C]. Similar to CNP, application
of ANP also led to the potentiation of IpH6.4
in small/medium-diameter DRG neurons
from TRPV1/ but not from TRPV1/
mice (data not shown).
We next determined the effect of CNP
on the H dose–response relationship of
TRPV1-mediated IpH activation in small/
medium-diameter DRG neurons that are
capsaicin sensitive. CNP application led
to a significant leftward shift in the H
dose–response relationship of TRPV1-
mediated IpH [EC50 pH 5.6 0.02 (n
12) and pH6.1 0.04 (n 14) for vehicle
and CNP-treated neurons, respectively;
Fig. 5D]. These data suggest that, in the
presence of CNP, the pH sensitivity of
TRPV1 is significantly shifted, such that it
has the potential to be activated by tissue
acidosis associated with tissue injury
and inflammation.
Given that CNP application to DRG
neurons led to the translocation of PKC
to the cell periphery (Fig. 4) and that
CNP-induced potentiation of ICap could
be completely attenuated by the blockade
of PKC activity (Fig. 2C), we next deter-
mined the precise intracellular signaling
cascades underlying CNP potentiation of
TRPV1 activity in response to acidic pH.
Pretreatment ofDRGneuronswith inhib-
itors of G-mediated activation of PLC
(gallein, 100M), PLC activity (U73122,
5 M), or PKC activity (BIM, 1 M) led to
the attenuation of CNP-induced potenti-
ation of peak IpH6.4 [1.76  0.3- and
2.07  0.4-fold increase in third and
fourth IpH6.4, respectively, for gallein
group (n 11); 2.08 0.43- and 4.11
1.82-fold increase in third and fourth
IpH6.4, respectively, for PLC group (n 
8); and 1.08 0.08- and 1.35 0.09-fold
increase in third and fourth IpH6.4, respec-
tively, for BIM group (n  11); Fig. 6A].
However, as observed for peak ICap (Fig.
2C), pretreatment of neurons with the
PKA inhibitor (KT5720, 400 nM) did not
attenuate CNP-induced potentiation of peak IpH6.4 [5.89 0.79-
and 9.79  1.87-fold increase in third and fourth IpH6.4, respec-
tively; Fig. 6A]. Together, these data suggest that CNPpotentiates
TRPV1-mediated proton-activated inward currents in mouse
DRG neurons via the G–PLC–PKC signaling cascade (Fig.
6B), although it is possible that other second-messenger signal-
ing pathways might be involved in the CNP potentiation of
TRPV1 currents.
It has been shown that PKC-induced potentiation of TRPV1
channel activity is governed by direct phosphorylation of the
channel protein at three putative Ser/Thr residues S502, T704,
Figure 5. CNP specifically sensitizes TRPV1-mediated acidic pH-induced inward currents in mouse DRG neurons. A, Represen-
tative sets of traces of four successive proton (pH 6.4 extracellular buffer for 5 s; with 1 min interval) activated currents (IpH 6.4) in
capsaicin-sensitive (left panel sets) and capsaicin-insensitive (right panel sets) small/medium-diameter cultured mouse DRG
neurons, with or without continuous extracellular perfusion of CNP (10 nM) after the second IpH 6.4.B, Representative sets of traces
of four successive IpH 6.4 recorded fromsmall/medium-diameter culturedmouseDRGneuronsobtained from TRPV1
/mice,with
orwithout continuous extracellular perfusion of CNP (10 nM) after the second IpH 6.4. C, Quantification of IpH 6.4 fromexperiments as
shown in A andB. Data are presented asmean SEM of fold increase in peak IpH 6.4 normalized to the second IpH 6.4, and n values
are shown in parentheses for each genotype/current/treatment group. *p
 0.05, significantly different compared with the
respective IpH 6.4 for the vehicle group (one-wayANOVAwith post hoc Dunnett’s correction).D, CNP treatment (10 nM for 5min) led
to a leftward shift in the pH dose–response relationship of IpH in capsaicin-sensitive small/medium-diameter culturedmouse DRG
neurons. Data are presented asmean SEMof inward currents in response to pH 7.4, 6.8, 6.4, 6.8, 5.4, and 4.8, normalized to the
peak amplitude of IpH 4.8, and fitted with the Hill equation. The n values and EC50 pH values are mentioned in the panel for vehicle
and CNP treatment groups.
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and S800 (Numazaki et al., 2002; Bhave et
al., 2003). To verify whether these three
PKC phosphorylation sites in TRPV1 are
essential for the CNP potentiation of
channel activity, we performed whole-cell
voltage-clamp analysis of TRPV1 channel
modulation in HEK293T cells heterolo-
gously expressing rTRPV1 and hNPR-C.
CNP application (10 nM) led to the poten-
tiation of peak ICap in HEK293T cells co-
expressing rTRPV1 and NPR-C [3.08 
1.28- and 8.82 2.8-fold increase in third
and fourth ICap, respectively (n 11); Fig.
7A,B]. CNP (10 nM) also potentiated
peak ICap in HEK293T cells expressing
only rTRPV1, without the cotransfection
of the plasmid containing NPR-C cDNA;
however, with a time delay [1.22  0.27-
and 12.5  4.1-fold increase in third and
fourth ICap, respectively (n  9); Fig.
7A,B]. This led us to suspect that NPR-C
is endogenously expressed in HEK293T
cells. Indeed, RT-PCR analysis of total
mRNA from HEK293T cells showed ex-
pression of all three NPRs, NPR-A/B/C, in
this cell line (Fig. 6C). The delay in CNP-
induced potentiation of TRPV1 currents in
HEK293T cells comparedwithmouseDRG
neurons could presumably be attributable
to an inefficient Gi coupling to NPR-C or
availability of significantly lesser pool of
Gi-coupled NPR-C in these cells. As such,
we used this cell line to affirm the involve-
ment of PKC in the potentiation of TRPV1
channel activitybyCNP,by transfecting sin-
gle, double, and triple Ala mutant TRPV1
channels at three putative PKC phosphory-
lation sites, S502, T704, and S800, in
HEK293T cells. We found that CNP poten-
tiation of ICap was reduced in S502A and
S800A, but not T704A, single mutants and
almost abolished in cells expressing
TRPV1–S502A/S800A double and
TRPV1–S502A/T704A/S800A triple mu-
tants compared with cells expressing
rTRPV1–WT [22.4  4.6-, 9.5  5.6-,
23.1  12.3-, 8.6  1.9-, 3.4  0.7-, and
3.8  1.2-fold increases in fourth ICap
(normalized to second ICap) for, respec-
tively, WT (n  12), S502A (n  10),
T704A (n  6), S800A (n  12), S502A/S800A (n  14), and
S502A/T704A/S800A (n  13) channels; Fig. 7D]. Collectively,
these results suggest that CNP-induced strong potentiation of
TRPV1 channel activity is mediated via PKC activation and sub-
sequent modification of TRPV1 protein primarily at two amino
acid residues: S502 and S800.
CNP increases the frequency of AP firing in DRG neurons
Because CNP potentiates TRPV1 channel activity, we next eval-
uated whether sensitization of TRPV1 by CNP alters the excit-
ability of DRG neurons, by whole-cell current-clamp recordings
in cultured mouse DRG neurons. Application of capsaicin (50
nM, 5 s) induced AP firings; however, APs were mostly absent
or at low frequency during the second capsaicin application (50
nM,5 s) after a 1 min wash period (Fig. 8A), likely as a result of
Ca2-dependent desensitization of the TRPV1 channel (Koplas
et al., 1997). In contrast, treatment with CNP (10 nM, 1 min)
between the capsaicin applications led to amarked increase in the
frequency of second capsaicin-induced AP firing (Fig. 8A). CNP
application (10 nM, 1min) also led to increasedAP firing frequency
during extracellular pH 6.8 application, specifically in capsaicin-
sensitive, but not in capsaicin-insensitive, small/medium-diameter
cultured mouse DRG neurons (Fig. 8B). Furthermore, CNP appli-
cation did not lead to any increase in pH 6.8-induced AP firing
frequency in small/medium-diameter DRG neurons from
TRPV1/ mice (Fig. 8C). Similar to CNP, application of ANP to
Figure 6. G/PLC/PKC-mediated intracellular signaling underlies CNP-induced sensitization of TRPV1 in mouse DRG neu-
rons. A, Quantified data are shown from whole-cell voltage-clamp experiments with four successive IpH 6.4, with continuous
extracellular application of CNP (10 nM), with orwithout pharmacologicalmodulators after the second IpH 6.4 in capsaicin-sensitive
small/medium-diameter cultured mouse DRG neurons, as in experiments shown in Figure 5, A and C. Data for vehicle and CNP
treatment groups from Figure 4C are replotted here for comparison. All the data are presented as mean SEM of fold increase in
peak IpH 6.4 normalized to the second IpH 6.4, and n values are given for each treatment group. *p
 0.05, significantly different
compared with the respective IpH 6.4 for the vehicle group (one-way ANOVA with post hoc Dunnett’s correction). The CNP-induced
potentiation of IpH 6.4was significantly reduced by pretreatmentwith the inhibitors of G-mediated activation of PLC (gallein,
100M), PLC activity (U73122, 5M), and PKC activity (BIM, 1M), but not by the inhibitor of PKA activity (KT5720, 400 nM).B,
A schematicmodel of CNP-induced sensitization of TRPV1 channel activity via G–PLC–PKC signaling inmouse DRG neurons,
as verified experimentally in A.
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small/medium-diameter DRG neurons also led to increased AP fir-
ing frequency during capsaicin and pH 6.4 applications (data not
shown). These data further confirm our hypothesis that CNP-
induced potentiation of TRPV1 activity leads to increased sensory
neuron firing in response to mild extracellular acidic conditions.
CNP injection leads to the development of acute thermal
hyperalgesia and is dependent on G–TRPV1 signaling
Given the ability of CNP to sensitize TRPV1 channel activity and
strongly potentiate nociceptor firing, we next tested whether
CNP administration could lead to the development of thermal
hyperalgesia in mice. Intraplantar injection of different concen-
trations of CNP (10l of 500 nM and 10M in saline) to mice led
to the development of thermal hyperalgesia ipsilateral to the in-
jected hindpaw (quantified by a signifi-
cant decrease in the PWL to a focused
high-intensity beam of light on the plan-
tar surface) compared with saline injec-
tion. CNP-induced thermal hyperalgesia
was observed within 30 min of injection,
which persisted for at least 6 h after the
injection but subsequently recovered to
baseline-level PWLs after 24 h (Fig. 9A).
No significant decreases in the PWLs of
contralateral paws were observed in re-
sponse to CNP injection (Fig. 9A). Injec-
tion of 10 and 100 nM CNP displayed
reduced PWLs, with significant decreases
at the 4 h time point after 100 nM CNP
injection, compared with the saline injec-
tion group (Fig. 9A). We then evaluated the
roleof theCNP–G–TRPV1signalingaxis
in the development of acute thermal hyper-
algesia. Intraperitoneal injection of gallein
(100 mg/kg), a specific inhibitor of G-
mediated activationof PLC, 30minbefore
intraplantarCNP injection led to significant
attenuation of CNP-induced acute thermal
hyperalgesia (Fig. 9B). The magnitude of
gallein-mediated attenuationof thermalhy-
peralgesia at 6 h after injection was abol-
ished compared with 30 min, 2 h, and 4 h
time points, possibly attributable to the
rapid urinary elimination of gallein. Fur-
thermore, intraperitoneal injection of
AMG9810 (30 mg/kg), a specific inhibitor
of TRPV1, 30 min before intraplantar CNP
injection led to the blockade of the develop-
ment of thermal hyperalgesia (Fig. 9B). No
significant decreases in the PWLs of con-
tralateral pawswere observed in response to
gallein and CNP or AMG9810 and CNP in-
jections (Fig. 9B), as well as in response to
gallein or AMG9810 injection alone (Fig.
9B). Furthermore, to genetically verify the
key role of TRPV1 in CNP-induced devel-
opment of thermal hyperalgesia, we per-
formed intraplantar injection of CNP into
TRPV1/ mice and observed no signifi-
cant decrease in thePWLs inboth ipsilateral
and contralateral hindpaws compared with
saline-injected controls (Fig. 9C). Collec-
tively, these results suggest that peripheral
administration of CNP recruits a noncanonical G–PLC–PKC
signaling pathway to sensitize TRPV1 channel activity and nocicep-
tor firing to induce the development of thermal hyperalgesia.
Discussion
Our study demonstrates that functional NPR-A/B/C are ex-
pressed in mouse DRG neurons, in which CNP and ANP, but not
BNP, induce sensitization of TRPV1 channel activity that is in-
dependent of classical NPR-A/B–cGMP–PKG signaling. Rather,
NP sensitization of TRPV1 is mediated through a noncanonical
NPR-C–G–PLC–PKC signaling module, as evidenced by the
attenuation of CNP-induced modulation of TRPV1 activity by
specific pharmacological blockade of these signaling compo-
nents. Such modulation of TRPV1 channel activity leads to
Figure 7. CNP/NPR-C/PKC-induced sensitization of TRPV1 activity is dependent on two PKC phosphorylation sites in the chan-
nel protein.A, Representative traces of TRPV1 currents inHEK293T cells either coexpressing rTRPV1andhNPR-C (top) or expressing
rTRPV1 alone (bottom) in response to four successive applications of capsaicin (20 nM for 5 s; with 2 min interval), with the
continuous extracellular perfusion of CNP (10 nM) after the second ICap.B, Quantification of ICap for experiments as shown inA. Data
are presented asmean SEM of fold increase in peak ICap normalized to second ICap; n values are given for each expression group.
*p
 0.05, significantly different comparedwith respective second ICap currents (one-way ANOVAwith post hoc Dunnett’s correc-
tion). C, Representative RT-PCR analysis of endogenous NPR expression in HEK293T cells with primers specific for NPR-A, NPR-B,
and NPR-C, as well as for GAPDH as a housekeeping control. Amplicons of RT-PCR reactions from isolatedmouse DRG neuron RNAs
are loaded for comparison. D, Quantification of fold increase in ICap for experiments as shown in A, from HEK293T cells expressing
rTRPV1 wild-type channel (TRPV1–WT), or single, double, and triple PKC phosphorylation site mutant rTRPV1 channels. Data are
presented asmean SEMof fold increase in peak fourth ICap normalized to second ICap;n values are shown in parentheses for each
expression group. *p 
 0.05, significantly different compared with TRPV1–WT (one-way ANOVA with post hoc Dunnett’s
correction).
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nociceptor sensitization to mild and
pathophysiologically relevant acidic con-
ditions and is absent in TRPV1/ DRG
neurons. Furthermore, intraplantar CNP
injection induces thermal hyperalgesia in
WT mice, but not inTRPV1/mice, and
is significantly attenuated by systemic ad-
ministration of G or TRPV1 inhibitors.
Together, these findings suggest that CNP
recruits a novel noncanonical G–
PLC–PKC–TRPV1 signaling pathway to
induce nociceptor sensitization and ther-
mal hyperalgesia, which likely takes place
in a variety of tissue injury and inflamma-
tory conditions.
The influence of NPs on inflammatory
pain has been suggested recently, with
contrasting observations on individual
NPs. Intrathecal BNP injection inhibits
inflammatory thermal hyperalgesia in-
duced by the injection of complete
Freund’s adjuvant (CFA) into rat hind-
paw, without any significant effect on me-
chanical hypersensitivity (Zhang et al.,
2010). Their study also found that intra-
thecal BNP injection led to a reduction in
formalin-induced nocifensive behav-
iors. Mechanistically, BNP attenuates
glutamate-induced AP firing in small-
diameter rat DRG neurons. Furthermore,
these effects were attributed to NPR-A–
cGMP–PKG signaling, leading to increased
BKCa current density (Zhang et al., 2010).
Interestingly, BNP alone did not have any
influence on AP firing (Zhang et al., 2010).
Incontrast to theseantinociceptive effectsof
BNP, direct and rapid development of me-
chanical allodynia was observed in rats dur-
ing intrathecal injection of CNP and
8-pCPT-cGMPbut notANP (Schmidtko et
al., 2008a; Heine et al., 2011). It was sug-
gested that CNP-induced mechanical allo-
dynia is mediated through cysteine-rich
protein 2, a downstream effector of in-
creased PKG activity (Schmidtko et al.,
2008b). Interestingly, our study found that,
in addition to NPR-A/B, mouse DRG neurons also express
NPR-C, in which it couples to Gi. Application of CNP led to
PKC activation through Gi–G–PLC-mediated intracellular
signaling. Furthermore, intraplantar injection of CNP led to the
development of thermal hyperalgesia that was dependent on G-
mediated signaling, leading to enhanced TRPV1 activity. To this
end, TRPV1/mice did not exhibit CNP-induced thermal hyper-
algesia. Collectively, NPs exert distinct effects on inflammatory
thermal and mechanical hypersensitivities. NPR-A/B–cGMP–
PKG signaling in the DRG neuron central axons projecting to the
spinal cord dorsal horn contributes to the development of mechan-
ical allodynia (Schmidtko et al., 2008a,b;Heine et al., 2011),with the
exception of intrathecal BNP, which exerts an analgesic effect on
CFA-induced thermal hyperalgesia (Zhang et al., 2010). Our study
suggests that CNP–G–PKC–TRPV1 signaling in the peripheral
afferents contributes to the development of thermal hyperalgesia.
Furthermore, widespread expression of NPR-B/C in DRG neurons
of all sizes andCNP-induced increases in cGMPproduction in neu-
rons collectively suggest a potential involvement of CNP in sensory
afferent sprouting/bifurcation in theperipheryand inductionofme-
chanical allodynia/hyperalgesia, which warrants thorough experi-
mental verification of this idea.
Our analysis of NP modulation of TRPV1 in mouse DRG
neurons revealed that both ANP and CNP significantly potenti-
ate channel activity and subsequently enhance AP firing fre-
quency. In contrast, BNP did not have such an effect. This is
consistent with a previous report in which no direct effects of
BNP on AP firing were found in DRG neurons (Zhang et al.,
2010). Furthermore, our study shows no involvement of cGMP/
PKG activity in NP-induced potentiation of TRPV1 currents,
which rules out any modulation of channel activity by NPR-A/B-
mediated signaling in DRG neurons. NPR-C has been suggested
as the NP clearance receptor (Pandey, 2005a; Potter et al., 2006),
yet other reports suggest that NP binding to NPR-C leads to activa-
Figure 8. CNP sensitizes AP firing in response to TRPV1 activation in mouse DRG neurons. Representative traces of AP firings
induced by two successive applications of 50 nM capsaicin (A) or pH 6.8 extracellular buffer (B, C), with or without the continuous
extracellular application of CNP (10 nM for 1 min) between the agonist applications obtained from small/medium-diameter
culturedDRGneurons from TRPV1/ (A,B) and TRPV1/ (C)mice. Note that CNP-mediated sensitization of pH6.8-inducedAP
firingwas observed only in capsaicin-sensitive (left panels inB) but not in capsaicin-insensitive (right panels inB) small/medium-
diameter cultured DRG neurons from TRPV1/ mice. No CNP-induced sensitization of pH 6.8-induced AP firing is observed in
small/medium-diameter DRG neurons from TRPV1/mice (C).
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tion of Gi–G–PLC-mediated intracellular signaling pathways
innumerous cell types (Levin, 1993; Anand-Srivastava, 2005). In
fact, our results from the coimmunoprecipitation, ERK1/2 phos-
phorylation, and PKC translocation assays strongly suggest the exis-
tence of a functional NPR-C–Gi–G–
PLC–PKC signaling cascade in mouse
DRG neurons. It was shown previously that
the affinities of CNP and ANP for NPR-C
exceed that of BNP (He et al., 2001; Anand-
Srivastava, 2005), which provides yet
another explanation for the lack of BNP-
induced potentiation of TRPV1 currents in
our study. As such, our results suggest a
novel Gi–G–PLC–PKC signaling
pathway for a GPCR-mediated modula-
tion of TRPV1 and subsequent nociceptor
sensitization, which otherwise have been
shown to be mediated primarily through
Gq- or Gs-coupled GPCRs (Basbaum et
al., 2009; Patapoutian et al., 2009). High
concentrations of morphine were shown to
directly activate and potentiate TRPV1 cur-
rents inmouseDRGneurons (Forster et al.,
2009). Considering the fact that many opi-
oid receptors induce Gi-coupled down-
stream signaling (Standifer and Pasternak,
1997;Stein,2003), it is tempting to speculate
that sensitization of TRPV1 channel activity
via high doses of morphine (Forster et al.,
2009) could be mediated through Gi–
G–PLC–PKC signaling, a hypothesis
that needs to be verified experimentally.
Activity and expression of TRPV1 in
sensory afferents has been shown to
undergo diverse modulations by a large
number of proinflammatory mediators,
cytokines, chemokines, and bioactive
peptides, mainly by influencing the phos-
phorylation state of the channel protein.
The protein kinases PKC, PKA, p38MAPK,
and Src are activated downstreamas a result
of activation of a variety of receptors for in-
flammatory mediators in sensory neurons/
afferents, which subsequently lead to direct
phosphorylation-dependent modulation
of TRPV1 channel activity and nociceptor
sensitization (Bhave et al., 2002, 2003; Ji et
al., 2002; Mohapatra and Nau, 2005;
Hucho and Levine, 2007; Patapoutian et
al., 2009). Activation of PKC and subse-
quent phosphorylation-dependent modu-
lation of TRPV1 channel activity has been
shown to be a convergent mechanism un-
derlying nociceptor sensitization by several
mediators (Bhave andGereau, 2004;Hucho
and Levine, 2007; Basbaum et al., 2009; Pa-
tapoutian et al., 2009; Gold and Gebhart,
2010; Kuner, 2010). PKC directly phos-
phorylates TRPV1 at amino acid residues
S502, T704, S774, and S800 (Numazaki et
al., 2002; Bhave et al., 2003). Indeed, our re-
sults demonstrated that substitution muta-
tion of two of these residues, S502A and
S800A, abolished CNP-induced potentiation of TRPV1 channel ac-
tivity. Phosphorylation of these residues in TRPV1by PKChas been
shown to potentiate the heat activation of the channel at tempera-
turesbelowbody temperature andunder conditionsofmild acidosis
Figure 9. CNP injection in mouse hindpaw leads to the development of thermal hyperalgesia in a G/TRPV1-dependent
manner. A, Mice (TRPV1/) were injected with either saline or different concentrations of CNP (10 nM, 100 nM, 500 nM, and 10
M) in their right hindpaw after baseline assessment of PWLs to a focused high-intensity beam of light on the plantar surface in a
Hargreaves plantar analgesia meter, followed by the determination of PWLs after 30 min, 2 h, 4 h, 6 h, and 24 h of CNP injection.
Data are presented as mean SEM PWLs of ipsilateral (left) and contralateral (right) hindpaws of uninjected (control), saline-
injected, and CNP-injected mice (n 6 for each group, with the exception of 10M CNP, for which n 10). *p
 0.05, **p

0.01, and***p
0.001, significantly different comparedwithPWLsof saline-injectedmice at the respective timepoints (one-way
ANOVAwith post hoc Bonferroni’s correction).B, The CNP-induced decrease in PWLwas significantly attenuated by preinjection of
the inhibitor of G-mediated activation of PLC, gallein (100 mg/kg, i.p.), and the specific inhibitor of TRPV1, AMG9810 (30
mg/kg i.p.), administered 30 min before CNP injections. Data are presented as mean SEM PWLs of ipsilateral and contralateral
hindpaws of gallein CNP-injected and AMG9810 CNP-injected mice (n 6 for each). PWL data of ipsilateral paws for CNP
injection group from A are plotted alongside for comparison. #p
 0.05, ##p
 0.01, and ###p
 0.001, significantly different
compared with CNP-injected PWLs at the respective time points (one-way ANOVA with post hoc Bonferroni’s correction). C, CNP
injection (10M) did not lead to any significant change in the PWLs of TRPV1/mice. Data are presented asmean SEMPWLs
of ipsilateral and contralateral hindpaws of uninjected, saline-injected, and CNP-injected mice (n 5 for each).
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(Vellani et al., 2001; Numazaki et al., 2002; Bhave et al., 2003). This
phenomenon ismanifested in our in vivo observations showing that
CNP inductionof thermal hyperalgesia is dependent onG signal-
ing and TRPV1, although the involvement of other sensory ion
channels, such as TRPA1, TRPV4, and Nav channels, cannot be
ruled out. Based on the role of NPR-B–cGMP–PKG signaling in
neurite bifurcation (Schmidt et al., 2009), along with our observa-
tiononCNP-inducedcGMPproduction inDRGneurons, it is plau-
sible that CNP might also influence peripheral mechanical
hypersensitivity. Our future studies will focus on a thorough inves-
tigation along these lines.
Pathological modification/activation of TRPV1 and subse-
quent nociceptor sensitization by mildly acidic conditions has
beenproposed as one of the principalmechanismsunderlying the
development of inflammatory thermal hyperalgesia (Hucho and
Levine, 2007; Basbaum et al., 2009; Gold and Gebhart, 2010;
Kuner, 2010). Our results clearly show that CNP treatment shifts
the H dose–response relationship of TRPV1 activation, such
that the channel is activated in mildly acidic pH ranges. To this
end, our results provide evidence of TRPV1-dependent sensiti-
zation of nociceptor firing at pH 6.8 in response to CNP that is
within a tissue acidosis range associated with injury and inflam-
matory conditions, including arthritic joints (Dray and Read,
2007; Hucho and Levine, 2007; Gold and Gebhart, 2010; Kuner,
2010). In view of pain associated with inflamed arthritic joints,
TRPV1 modulation in sensory afferents is suggested to play a key
role in both thermal andmechanical pain sensitization associated
with rheumatoid arthritis and osteoarthritis (Dray and Read,
2007; Premkumar and Sikand, 2008; Gold and Gebhart, 2010;
Kuner, 2010). Elevated levels (approximately fivefold) of CNP
have been detected in the serum of rheumatoid arthritis patients
(Olewicz-Gawlik et al., 2010a), and CNP has also been shown to
be secreted at elevated levels by vascular endothelial cells during
stimulation by inflammatory mediators such as IL-1/ and
TNF- (Suga et al., 1993). Studies aimed at determining the tis-
sue levels of CNP at the site of injury and inflammation are
needed to precisely understand the role of CNP-induced nocice-
ptor sensitization in a wide variety of inflammatory conditions.
Our comparison of CNP with other major inflammatory media-
tors, such as PGE2 and BK, revealed that CNP is a potent modu-
lator of TRPV1 and nociceptor sensitization at relatively low
concentrations (nanomolar range), which is also supported by
dose-dependent induction of cutaneous thermal hyperalgesia in
mice. Therefore, it is plausible that CNP-induced sensitization of
TRPV1 activity at mildly acidic pH and constitutive nociceptor
sensitization constitutes one of the mechanisms underlying the
induction of thermal hyperalgesia in a wide variety of acute and
chronic inflammatory conditions. In conclusion, our study dem-
onstrates a novel noncanonical NP signaling pathway that in-
duces thermal hyperalgesia via phosphorylation-dependent
modulation of TRPV1 channel activation by protons and nocice-
ptor sensitization.
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